Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors

Journal of Investigative Medicine

Volumn 49, Issue 2, 2001, Pages 195-204

  Visser, J ^a   Lentjes, E ^a   Haspels, I ^a   Graffelman, W ^a   Blauw, B ^a   De Kloet, R ^a   Nagelkerken, L ^a  

^a TNO   (Netherlands)

Author keywords

Chronic fatigue syndrome; Cytokines; Glucocorticoid receptors; Glucocorticoids

Indexed keywords

CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; MALE; MONONUCLEAR CELL; RECEPTOR AFFINITY; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035116020     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2001.34047     Document Type: Article

References (55)

1. Chronic fatigue syndrome: A working case definition
2. The chronic fatigue syndrome: A comprehensive approach to its definition and study
3. Neurobiological aspects of the chronic fatigue syndrome
4. Chronic fatigue syndrome. Point and counterpoint
5. Low NK syndrome and its relationship to chronic fatigue syndrome
6. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome
7. Immunologic abnormalities associated with chronic fatigue syndrome
8. Lymfocyte phenotype and function in the chronic fatigue syndrome
9. Chronic fatigue syndrome: A clinical and laboratory study with a well matched control group
10. Immunologic abnormalities in chronic fatigue syndrome
11. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome
12. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome
13. Immune responses associated with chronic fatigue syndrome: A case-control study
14. A study of the immunology of the chronic fatigue syndrome: Correlation of immunologic parameters to health dysfunction
15. Immunological abnormalities in patients with chronic fatigue syndrome
16. Chronic fatigue syndrome: Clinical condition associated with immune activation
17. CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-γ production and increased sensitivity to dexamethasone
18. Upregulation of the 2-5A synthetase/Rnase L antiviral pathway associated with chronic fatigue syndrome
19. A 37 kDa 2-5A binding protein as a potential biochemical marker for Chronic Fatigue Syndrome
20. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome
21. Serotonin mediated activation of the hypothalamic-pituitary-adrenal-axis in chronic fatigue syndrome
22. The low dose ACTH test in chronic fatigue syndrome and health
23. Antidepressants and hypothalamic-pituitary adrenocortical regulation
24. Corticosteroid receptor function is decreased in depressed patients
25. Glucocorticoid receptors, fibromyalgia and low back pain
26. Hormonal influences on stress-induced neutrophil mobilization in health and chronic fatigue syndrome
27. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: A randomized controlled trial
28. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain
29. Properties and interpretation of the Woolf and Scatchard plots in analyzing data from steroid receptor assays
30. Differential regulation of Interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro
31. Glucocorticoid receptors in bronchial epithelial cells in asthma
32. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements
33. Contrasting effects of glucocorticoids on the capacity of T celts to produce growth factors interleukin-2 and interleukin-4
34. Glucocorticoid resistance in asthma
35. Abrogation of the suppressive effects of dexamethasone by PKC activation or CD28
36. Combination of IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids
37. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids
38. Role of transcriptional activation of 1kBα in mediation of immunosuppression by glucocorticoids
39. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis
40. Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells
41. Antagonism of glucocorticoid receptor transcriptional activation by the c-jun N-terminal kinase
42. A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo
43. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
44. Elevated concentration of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
45. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression
46. Glucocorticoid receptors in depression: Relationship to the dexamethasone suppression test
47. Glucocorticoid receptors and depression
48. Low urinary cortisol excretion in patients with post-traumatic stress disorder
49. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome
50. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder
51. Glucocorticoids and immune function: Unknown dimensions and new frontiers
52. Neuroendocrine-immune system interactions and autoimmunity
53. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function
54. Hormones, peripherally activated prohormones and regulation of the Th 1/Th2 balance
55. Tumor necrosis factor alpha decreases and interleukin-10 increases the sensitivity of human monocytes to dexamethasone: Potential regulation of the glucocorticoid receptor